The effects of gefitinib in tamoxifen‐resistant and hormone‐insensitive breast cancer: A phase II study

E-ISSN： 1097-0215|126|8|1806-1816

ISSN： 0020-7136

Source： INTERNATIONAL JOURNAL OF CANCER, Vol.126, Iss.8, 2010-04, pp. : 1806-1816

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Research provides new hope for tamoxifen-resistant breast cancer patients

Women's Health, Vol. 4, Iss. 2, 2008-03 ,pp. : 115-117

Future Medicine

Access to resources Recommend Favorite

Approaches Targeted to Estrogen Receptors for Treatment of Tamoxifen-Resistant Breast Cancer: A Brief Overview

Oncology, Vol. 59, Iss. 1, 2000-11 ,pp. : 3-4

Karger

Access to resources Recommend Favorite

A Pure Antiestrogen, ICI 182,780, Stimulates the Growth of Tamoxifen-Resistant KPL-1 Human Breast Cancer Cells in vivo but not in vitro

Oncology, Vol. 55, Iss. 1, 1998-12 ,pp. : 23-34

Karger

Access to resources Recommend Favorite

Phase II Study of Gefitinib Readministration in Patients with Advanced Non-Small Cell Lung Cancer and Previous Response to Gefitinib

Oncology, Vol. 79, Iss. 5-6, 2011-04 ,pp. : 423-429

Karger

Access to resources Recommend Favorite

Prednisone plus Gefitinib versus Prednisone plus Placebo in the Treatment of Hormone-Refractory Prostate Cancer: A Randomized Phase II Trial

Oncology, Vol. 74, Iss. 3-4, 2008-08 ,pp. : 223-228

Karger

Access to resources Recommend Favorite